Investor Said Seeking To Sell 20% Stake In India's GVK Biosciences CRO
This article was originally published in PharmAsia News
Executive Summary
GVK Biosciences, an India-based contract-research organization, appears to be losing one of its largest benefactors as sources say U.S.-based Sequoia Capital, a venture capital fund, seeks a buyer for its 20% stake.